Anti-aging cubilose active peptide subjected to high-throughput screening by using molecular docking technology and application thereof
Through high-throughput screening and multi-step processing of molecular docking technology, efficient bird's nest enzyme solution products were prepared, solving the problem of cumbersome preparation process of bird's nest peptides and unclear characteristic peptides, and realizing bird's nest enzyme solution products in medicine, food, and health care wide application in fields such as products.
Patent Information
- Application Number
- CN202411193864.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-12-03
AI Technical Summary
The existing bird's nest processing technology is low, the preparation process of bird's nest polypeptides is cumbersome, and the amino acid sequence and efficacy of bird's nest characteristic peptides are unclear, which limits the widespread application of bird's nest polypeptide products in medicines, foods, health products and other fields.
High-throughput screening of active peptides of anti-aging bird's nests by molecular docking technology, and after heating, colloid milling, pulse electric field treatment, enzymatic lysis and ceramic membrane concentration were prepared to produce bird's nest enzyme products with high hydrolysis rate and high protein recovery. Characteristic peptide amino acid sequence and low molecular weight peptide with clear efficacy.
Improve the hydrolysis rate and protein recovery rate of bird's nest enzyme solution products, clarify the amino acid sequence and efficacy of characteristic peptides, have moderate moisturizing properties, promote cell synthesis FLG ability, prevent or slow UVB damage, promote cell scratch repair and wound healing , suitable for medicines, food, health products and cosmetics.
Smart Images

Figure BDA0005015803220000051 
Figure BDA0005015803220000061 
Figure BDA0005015803220000071
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bird's nest processing, and particularly relates to anti-aging bird's nest active peptides screened by high-throughput molecular docking technology and applications thereof. Background Art
[0002] As a natural food, bird's nest contains a variety of nutrients that are beneficial to the skin and can help the skin resist aging. Bird's nest polypeptides generated after protease hydrolysis have the effects of promoting cell proliferation, lowering blood pressure, and antiviral. Bird's nest polypeptides have a low molecular weight and are easily absorbed through the epidermis. They also have the properties of scavenging free radicals and inhibiting lipid peroxidation, which can protect cells from oxidative stress damage. Therefore, they have application potential in many fields.
[0003] At present, the traditional processing method of bird's nest is mainly steaming. The bird's nest product obtained by this rough processing method basically maintains the original macromolecular protein structure, and the protein molecular weight is too large to be completely absorbed by the human body. It is very important to make it into bird's nest polypeptide by a suitable method to improve the absorption of protein in bird's nest, but the preparation method of bird's nest polypeptide in the prior art still has some defects, such as low efficiency in the preparation process, cumbersome operation, unclear amino acid sequence and efficacy of bird's nest characteristic peptide segment, etc., which limits the market application of bird's nest polypeptide products. Therefore, it is necessary to further develop a method for preparing bird's nest enzymatic hydrolysis products with high hydrolysis rate, high protein recovery rate, characteristic peptide segment amino acid sequence and clear function, promote the wide application of bird's nest products in the fields of medicine, food, health care products, cosmetics, etc., and improve the economic value of bird's nest. Summary of the invention
[0004] The present invention aims to solve at least one of the technical problems existing in the prior art to a certain extent. To this end, the present invention provides anti-aging bird's nest active peptides screened by high-throughput molecular docking technology and their applications. The polypeptide of the present invention is derived from bird's nest, has the advantages of small molecular weight and good affinity with the transporter PepT1, and the bird's nest enzymatic hydrolysate containing the polypeptide of the present invention has moderate moisture retention, the ability to promote cell synthesis of FLG, the ability to prevent or slow down cell UVB damage, and the ability to promote cell scratch repair or animal skin wound or wound healing. It can be used to develop medicines, foods, health products or cosmetics, and has broad application prospects.
[0005] In the first aspect of the present invention, the present invention proposes a polypeptide. According to an embodiment of the present invention, it comprises: YY, FF, WW, AA or GG amino acid repeating sequence; the number of amino acid residues of the polypeptide is 3 to 8. The polypeptide according to the embodiment of the present invention is derived from bird's nest, has the advantages of small molecular weight and good affinity with the transporter PepT1, and the bird's nest enzymatic hydrolysate containing the polypeptide of the present invention has moderate moisture retention, the ability to promote cell synthesis of FLG, the ability to prevent or slow down cell UVB damage, and the ability to promote cell scratch repair or animal skin wound or wound healing. It can be used to develop medicines, foods, health products or cosmetics, and has broad application prospects.
[0006] In the second aspect of the present invention, the present invention proposes a method for preparing a bird's nest enzymatic hydrolysis product containing the polypeptide. According to an embodiment of the present invention, the method comprises the following steps: (1) heating the bird's nest and subjecting it to a colloid mill treatment to obtain a bird's nest homogenate; (2) subjecting the bird's nest homogenate to a pulse electric field treatment to obtain a bird's nest to be enzymatically hydrolyzed; (3) subjecting the bird's nest to be enzymatically hydrolyzed to an enzymatic hydrolyzate to obtain a bird's nest; (4) subjecting the bird's nest enzymatic hydrolyzate to a ceramic membrane concentration treatment, collecting the concentrated solution, and obtaining the bird's nest enzymatic hydrolyzate. The method for preparing the bird's nest enzymatic hydrolyzate according to an embodiment of the present invention has a high hydrolysis rate and a high protein recovery rate, and the obtained bird's nest enzymatic hydrolyzate has a high proportion of low molecular weight polypeptides, and a clear characteristic peptide amino acid sequence and efficacy.
[0007] In the third aspect of the present invention, the present invention proposes a bird's nest hydrolysate obtained by the aforementioned method or a bird's nest hydrolysate containing the aforementioned polypeptide. The bird's nest hydrolysate according to the embodiment of the present invention has a high proportion of low molecular weight polypeptides, a characteristic peptide amino acid sequence and clear efficacy, moderate moisture retention, the ability to promote cell synthesis of FLG, the ability to prevent or slow down cell UVB damage, and the ability to promote cell scratch repair or animal skin wound or wound healing, and can be used to develop medicines, foods, health products or cosmetics, and has broad application prospects.
[0008] In the fourth aspect of the present invention, the present invention proposes the use of the aforementioned polypeptide or the aforementioned bird's nest enzymatic hydrolysate in the preparation of a product. According to an embodiment of the present invention, the product has at least one of the following uses: maintaining or increasing the moisture content of the skin; preventing and / or slowing down skin aging; preventing and / or slowing down skin UVB damage; promoting the healing of skin wounds or wound surfaces.
[0009] Those skilled in the art will appreciate that the features and advantages described above for polypeptides and bird's nest enzymatic hydrolysates are also applicable to this application and will not be described in detail here.
[0010] In a fifth aspect of the present invention, the present invention provides a medicine, food, health product or cosmetic, which, according to an embodiment of the present invention, comprises: the aforementioned polypeptide or the aforementioned bird's nest enzymatic hydrolysate.
[0011] Those skilled in the art will appreciate that the features and advantages described above for the polypeptide and bird's nest enzymatic hydrolysate are also applicable to the medicine, food, health care product or cosmetic, and will not be elaborated here.
[0012] Additional aspects and advantages of the present invention will be given in part in the following description and in part will be obvious from the following description, or will be learned through practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] The above and / or additional aspects and advantages of the present invention will become apparent and easily understood from the description of the embodiments in conjunction with the following drawings, in which:
[0014] Figure 1 This is a graph showing the results of investigating the hydrolysis degree of the bird's nest enzymatic hydrolysates in Examples 1 to 26 and Comparative Examples 1 to 4 of the present invention;
[0015] Figure 2 This is a graph showing the results of investigating the protein recovery rate of the bird's nest enzymatic hydrolysates in Examples 1 to 26 and Comparative Examples 1 to 4 of the present invention;
[0016] Figure 3 This is a graph showing the results of investigating the DPPH free radical scavenging rate of the bird's nest enzymatic hydrolysates in Examples 1 to 26 and Comparative Examples 1 to 4 of the present invention;
[0017] Figure 4 This is a graph showing the results of investigating the mushroom tyrosinase inhibition activity of the bird's nest enzymatic hydrolysates in Examples 1 to 26 and Comparative Examples 1 to 4 of the present invention;
[0018] Figure 5 This is a graph showing the molecular weight distribution of the enzymatic hydrolyzate of the bird's nest according to an embodiment of the present invention; wherein EBNP-1, EBNP-2, and EBNP-3 represent three parallel samples of the enzymatic hydrolyzate of the bird's nest prepared under the same process conditions;
[0019] Figure 6 This is a result diagram of the quantitative proportion investigation of the molecular weight distribution of the bird's nest enzymatic hydrolysis product according to an embodiment of the present invention; wherein EBNP-1, EBNP-2, and EBNP-3 represent three parallel samples of bird's nest enzymatic hydrolysis products prepared under the same process conditions;
[0020] Figure 7 This is a graph showing the results of investigating the hygroscopicity of a freeze-dried sample of a bird's nest enzymatic hydrolyzate according to an embodiment of the present invention;
[0021] Figure 8 This is a graph showing the results of investigating the moisturizing ability of a freeze-dried sample of a bird's nest enzymatic hydrolyzate according to an embodiment of the present invention;
[0022] Fig. 9This is a graph showing the results of investigating the effect of freeze-dried samples of bird's nest enzymatic hydrolysates on HaCat cell viability according to an embodiment of the present invention;
[0023] Fig.10 This is a graph showing the results of investigating the effect of freeze-dried samples of bird's nest enzymatic hydrolysates on the expression level of FLG in HaCat cells according to an embodiment of the present invention;
[0024] Fig.11 This is a graph showing the effects of different degrees of UVB damage on HaCaT cell viability;
[0025] Fig.12 This is a graph showing the effects of different degrees of UVB damage on HaCaT cell morphology;
[0026] Fig.13 The present invention is a graph showing the effect of freeze-dried samples of bird's nest enzymatic hydrolysate on the viability of UVB-damaged HaCaT cells; wherein (A) is the survival of blank control group, Vc (positive control), and UVB radiation-induced cell damage 24 hours later; (B) is the survival of freeze-dried bird's nest enzymatic hydrolysate samples after intervention with UVB radiation-damaged HaCaT cells; (C) is a graph showing the statistical results of cell survival rate after blank control group, Vc (positive control), and bird's nest enzymatic hydrolysate intervened with UVB radiation-damaged HaCaT cells; (D) is a graph showing the EdU staining results of HaCaT cells after blank control group, Vc (positive control), and bird's nest enzymatic hydrolysate intervened with UVB radiation-damaged HaCaT cells; (E) is a graph showing the statistical results of cell proliferation rate after blank control group, Vc (positive control), and bird's nest enzymatic hydrolysate intervened with UVB radiation-damaged HaCaT cells; wherein Con represents blank control group, UV represents UVB (5J / cm 2 ) irradiation model group, Vc represents vitamin C positive control, EBNP-1, EBNP-100, and EBNP-1000 represent bird's nest enzymatic hydrolysate experimental groups with protein concentrations of 1 μg / mL, 100 μg / mL, and 1000 μg / mL, respectively;
[0027] Fig.14 The graphs are the results of investigating the effect of freeze-dried samples of bird's nest enzymatic hydrolysate products on HaCaT cell scratch repair according to an embodiment of the present invention; wherein (A) is the results of an in vitro scratch experiment investigating the "scratches" on HaCat monolayer cells; (B) is the results of a statistical investigation of the wound healing rate of in vitro scratches on HaCat monolayer cells under different conditions; (C) is the results of a statistical investigation of the percentage change rate of wound healing of in vitro scratches on HaCat monolayer cells under different conditions;
[0028] Fig.15The figures are the results of animal experiments on the skin repair effect of freeze-dried samples of bird's nest enzymatic hydrolysate according to the embodiments of the present invention; wherein (A) on the left is a schematic diagram of the animal modeling method for skin damage, and on the right is a graph showing the changes in mouse skin after applying 30% glycolic acid for 30 minutes; (B) is a graph showing the changes in mouse skin after applying different drugs to intervene in the damaged skin of mice and for different treatment times; (C) is a graph showing the results of mouse skin histology HE staining after applying different drugs to intervene in the damaged skin of mice; wherein EBNP-100 is an experimental group with a protein concentration of 100 μg / mL of the bird's nest enzymatic hydrolysate solution, Vc is a vitamin C positive control, and HA is a hyaluronic acid positive control group;
[0029] Fig.16 This is a graph showing the results of amino acid composition analysis of freeze-dried samples of bird's nest enzymatic hydrolysates according to an embodiment of the present invention;
[0030] Fig.17 The Vina scoring results of the hydrophobic amino acids A, AA, and AAA in the freeze-dried sample of the bird's nest enzymatic hydrolysate according to the embodiment of the present invention and the visualization result diagram of the spatial conformation of the binding site between the amino acid repeating sequences YYY, WWW, and FFF and the transporter PepT1;
[0031] Fig.18 This is a visualization result diagram of the spatial conformation of the binding sites of YFF, WFF and WWP with the transporter PepT1 in the freeze-dried sample of the bird's nest enzymatic hydrolysate according to an embodiment of the present invention. DETAILED DESCRIPTION
[0032] The embodiments of the present invention are described in detail below. The embodiments described below are exemplary and are only used to explain the present invention, and should not be understood as limiting the present invention.
[0033] It should be noted that the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. Further, in the description of the present invention, unless otherwise specified, the meaning of "plurality" is two or more.
[0034] The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0035] In this document, the terms “include” or “comprising” are open expressions, that is, including the contents specified in the present invention but not excluding other contents.
[0036] As used herein, the terms "optionally", "optional" or "optionally" generally mean that the subsequently described event or circumstance may but need not occur, and that the description includes instances where the event or circumstance occurs and instances where it does not.
[0037] Terms and Definitions
[0038] In this article, the term "FLG" is filaggrin, which is a key protein formed by the outermost layer of the skin (stratum corneum) to prevent water loss. Natural moisturizing factor is a hydrolyzed derivative of filaggrin (FLG).
[0039] In this article, the term "Vc" refers to vitamin C (Vc), which is a water-soluble vitamin that is often used as a positive control to evaluate the biological effects of other ingredients or formulations.
[0040] In this article, the term "HA" refers to hyaluronic acid (HA), which is a polysaccharide naturally present in the human body and has extremely strong moisturizing ability. It is used to compare its effects with other ingredients to demonstrate its effects and application potential in moisturizing and anti-aging.
[0041] The present invention provides a polypeptide, a method for preparing a bird's nest enzymatic hydrolysate containing the polypeptide, a bird's nest enzymatic hydrolysate and applications thereof, which will be described in detail below.
[0042] Peptides
[0043] The present invention proposes a polypeptide. According to an embodiment of the present invention, it includes: YY, FF, WW, AA or GG amino acid repeating sequence; the number of amino acid residues of the polypeptide is 3 to 8. The polypeptide according to the embodiment of the present invention is derived from bird's nest, has the advantages of small molecular weight and good affinity with the transporter PepT1, and the bird's nest enzymatic hydrolysate containing the polypeptide of the present invention has moderate moisture retention, the ability to promote cell synthesis of FLG, the ability to prevent or slow down cell UVB damage, and the ability to promote cell scratch repair or animal skin wound or wound healing. It can be used to develop medicines, foods, health products or cosmetics, and has broad application prospects.
[0044] According to an embodiment of the present invention, the number of amino acid residues in the polypeptide is 3.
[0045] According to an embodiment of the present invention, the amino acid sequence of the polypeptide is as shown in any one of WWT, WWL, WWF, WWP, WWS, WWW, AYY, MYY, WYY, YYF, YYS, YYE, TYY, YYC, YYQ, YYY, AFF, FFL, TFF, FFH, QFF, MFF, FFW, FFR, NFF, FFF, FFW, WWP, and WWS.
[0046] According to an embodiment of the present invention, the number of amino acid residues in the polypeptide is 4.
[0047] According to an embodiment of the present invention, the amino acid sequence of the polypeptide is as shown in any one of EAYY, YFYY, VFYY, YYVL, YYLL, YYYS, FAYY, YYGQ, YYNL, YYTA, FFLE, KVFF, LAFF, FFEL, FFSE, VFFL, FFGF, FFSY, FFTK, VFFG, VGFF, FFPA, FFTL, SRFF, FFCH, LAAF, LAAW, LAAL, YAAL, FAAR, RAAF, PGGF, and WGGF.
[0048] According to an embodiment of the present invention, the number of amino acid residues in the polypeptide is 5;
[0049] According to an embodiment of the present invention, the amino acid sequence of the polypeptide is shown in any one of YYSGQ, VTFFH, VAAGL, GFLAA, VAALL, YAATL, PAAQF, WAAQ, and LAPAA.
[0050] According to an embodiment of the present invention, the number of amino acid residues in the polypeptide is 8.
[0051] According to an embodiment of the present invention, the amino acid sequence of the polypeptide is shown in any one of FDLMYYPY, GAAPCPRD, VGTREAAF, SPGGHQIL, FGGNPGGF, FDLMNGGP, PRPAGGPI, and TGGAGPHW.
[0052] According to an embodiment of the present invention, the N-terminus and the C-terminus of the polypeptide are hydrophobic amino acid residues.
[0053] According to an embodiment of the present invention, the hydrophobic amino acid residue is selected from F, Y, W, L, I, V, A, P, G, M, C, S, T;
[0054] According to an embodiment of the present invention, the amino acid sequence of the polypeptide is shown in any one of WWL, WWP, WWS, WWW, YYF, YYY, and FFL.
[0055] According to an embodiment of the present invention, the polypeptide is derived from bird's nest.
[0056] Preparation method
[0057] The present invention proposes a method for preparing a bird's nest enzymatic hydrolysis product containing the above-mentioned polypeptide. According to an embodiment of the present invention, the method comprises the following steps: (1) heating the bird's nest and subjecting it to a colloid mill treatment to obtain a bird's nest homogenate; (2) subjecting the bird's nest homogenate to a pulse electric field treatment to obtain a bird's nest to be enzymatically hydrolyzed; (3) subjecting the bird's nest to be enzymatically hydrolyzed to an enzymatic hydrolyzate to obtain a bird's nest; (4) subjecting the bird's nest enzymatic hydrolyzate to a ceramic membrane concentration treatment, collecting the concentrated liquid, and obtaining the bird's nest enzymatic hydrolyzate. The method for preparing the bird's nest enzymatic hydrolyzate according to an embodiment of the present invention has a high hydrolysis rate and a high protein recovery rate. The obtained bird's nest enzymatic hydrolyzate has a high proportion of low molecular weight polypeptides, and the characteristic peptide amino acid sequence and efficacy are clear.
[0058] According to an embodiment of the present invention, in the colloid mill treatment: the colloid mill tooth gap is 30 to 70 μm, preferably 40 to 60 μm; the grinding time is 10 to 120 min, preferably 10 to 30 min.
[0059] According to an embodiment of the present invention, the pulse electric field treatment includes: passing the bird's nest homogenate through a pulse electric field treatment chamber for pulse electric field treatment; the electric field strength of the pulse electric field treatment chamber is 10 to 20 kv / cm, the pulse width is 1 to 5 μs, the frequency is 100 to 300 Hz, the time for the bird's nest homogenate to pass through the pulse electric field treatment chamber is 30 to 90 s, and the flow rate is 200 to 400 kg / h.
[0060] According to an embodiment of the present invention, the step (3) comprises: contacting the bird's nest hydrolyzate with alkaline protease or alkaline protease combined with pancreatic enzyme to perform enzymatic hydrolysis to obtain the bird's nest hydrolyzate.
[0061] According to an embodiment of the present invention, 15,000 to 25,000 U of the alkaline protease or alkaline protease combined with pancreatic enzyme is added per gram of the bird's nest hydrolyzate.
[0062] According to an embodiment of the present invention, the alkaline protease or alkaline protease combined with pancreatic enzyme comprises at least one of alkaline protease, flavor alkaline protease, alkaline protease combined with pancreatic enzyme, and flavor alkaline protease combined with pancreatic enzyme.
[0063] According to an embodiment of the present invention, the temperature of the enzymatic hydrolysis treatment is 50-60° C., and the time is 40-80 min.
[0064] According to an embodiment of the present invention, the ceramic membrane concentration treatment comprises: desalting and concentrating the bird's nest enzymatic hydrolysate through a ceramic membrane, wherein the pore size of the ceramic membrane is 50 to 100 nm.
[0065] According to an embodiment of the present invention, the method further comprises: freeze-drying the bird's nest enzymatic hydrolysis product to obtain a bird's nest enzymatic hydrolysis dried product.
[0066] Bird's nest enzymatic hydrolysate
[0067] The present invention proposes a bird's nest enzymatic hydrolysis product obtained by the aforementioned method. The bird's nest enzymatic hydrolysis product according to the embodiment of the present invention has a high proportion of low molecular weight polypeptides, a characteristic peptide amino acid sequence and clear efficacy, has moderate moisturizing properties, the ability to promote cell synthesis of FLG, the ability to prevent or slow down cell UVB damage, and the ability to promote cell scratch repair or animal skin wound or wound healing, can be used to develop medicines, foods, health products or cosmetics, and has broad application prospects.
[0068] use
[0069] The present invention proposes the use of the aforementioned polypeptide or the aforementioned bird's nest enzymatic hydrolysate in the preparation of a product. According to an embodiment of the present invention, the product has at least one of the following uses: maintaining or increasing the moisture content of the skin; preventing and / or slowing down skin aging; preventing and / or slowing down skin UVB damage; promoting the healing of skin wounds or wound surfaces.
[0070] Those skilled in the art will appreciate that the above-mentioned features and advantages of polypeptides and bird's nest enzymatic hydrolysates are also applicable to this application and will not be elaborated here.
[0071] According to an embodiment of the present invention, the product includes but is not limited to: at least one of medicines, foods, health products, and cosmetics.
[0072] According to an embodiment of the present invention, the medicine is used for preventing and / or healing skin UVB damage or skin wounds or wound surfaces.
[0073] According to an embodiment of the present invention, the health care product helps to improve the moisture status of the skin, helps to improve chloasma or helps to improve acne.
[0074] Medicines, food, health products or cosmetics
[0075] The present invention provides a medicine, food, health product or cosmetic. According to an embodiment of the present invention, it includes: the aforementioned polypeptide or the aforementioned bird's nest enzymatic hydrolysate.
[0076] Those skilled in the art will appreciate that the features and advantages described above for the polypeptide and bird's nest enzymatic hydrolysate are also applicable to the medicine, food, health care product or cosmetic, and will not be elaborated here.
[0077] The amino acid sequences involved in the present disclosure are shown in Table 1.
[0078] Table 1
[0079]
[0080]
[0081]
[0082] Determining the degree of hydrolysis and protein recovery rate of a freeze-dried sample of a bird's nest enzymatic hydrolysate containing the polypeptide is of great significance for ensuring the quality, nutritional value, authenticity identification, scientific research, etc. of bird's nest products. In the embodiments and comparative examples of the present invention, the OPA method is used to determine the degree of hydrolysis of a freeze-dried sample of a bird's nest enzymatic hydrolysate containing the polypeptide. The protein content of the enzymatic supernatant and the protein content of the bird's nest are determined by the Kjeldahl nitrogen determination method in GB5009.5-2016 "National Food Safety Standard Determination of Protein in Food", and the protein recovery rate is calculated. The protein recovery rate is calculated according to Formula 1:
[0083]
[0084] The DPPH free radical scavenging ability determination is a rapid and simple experimental method for evaluating the antioxidant activity of a sample in vitro, and this method is used to quantitatively evaluate the antioxidant capacity of a sample. In the examples and comparative examples of the present invention, the DPPH free radical scavenging ability of a freeze-dried sample of a bird's nest enzymatic hydrolyzate containing the polypeptide was determined by the following method:
[0085] (1) Sample solution preparation: The freeze-dried sample of the bird's nest enzymatic hydrolysate containing the polypeptide is prepared into a sample solution using ultrapure water (the freeze-dried samples of the bird's nest enzymatic hydrolysate containing the polypeptide prepared in Examples 1 to 26 and Comparative Examples 1 to 4 are all prepared to 1000 μg / mL);
[0086] (2) Test solution configuration:
[0087] A0: Add 2 mL of anhydrous ethanol to neutralize 2 mL of DPPH free radical solution in a test tube.
[0088] A1: Add 2 mL of sample solution to neutralize 2 mL of DPPH free radical solution in a test tube.
[0089] A2: Add 2 mL of sample solution and 2 mL of anhydrous ethanol to the test tube.
[0090] (3) The above-mentioned test solution was mixed evenly and placed at room temperature for 30 minutes. Finally, the test mixed solution was centrifuged at 5000r / min for 10 minutes. The absorbance value of the supernatant after centrifugation was measured at 517nm to calculate the scavenging rate of the sample for DPPH free radicals. The scavenging rate of the lyophilized sample of the bird's nest enzymatic hydrolysate containing the polypeptide for DPPH free radicals was calculated according to Formula 2:
[0091]
[0092] in,
[0093] A0 is the absorbance value of 2 mL anhydrous ethanol + 2 mL DPPH free radical solution;
[0094] A1 is the absorbance value of 2 mL sample solution + 2 mL DPPH free radical solution;
[0095] A2 is the absorbance value of 2 mL sample solution + 2 mL anhydrous ethanol.
[0096] Tyrosinase is a key enzyme in the synthesis of melanin. The inhibition of its activity can reduce the production of melanin, thereby achieving the effect of whitening the skin. Determining the tyrosinase inhibition rate of a sample is a method for evaluating the antioxidant capacity of a sample. Among them, mushroom tyrosinase is often used as a model of tyrosinase in research due to its easy access and easy operation characteristics, and is used to screen and evaluate potential tyrosinase inhibitors. In the embodiments and comparative examples of the present invention, the mushroom tyrosinase inhibition rate of a freeze-dried sample of a bird's nest hydrolysate containing the polypeptide is determined by the following method: the bird's nest hydrolysate containing the polypeptide obtained in Examples 1 to 26 and Comparative Examples 1 to 4 is respectively redissolved in phosphate buffer (0.05 mol / L, pH 6.8) into a sample solution of 10 mg / mL, the reaction system is configured according to Table 2, and the mushroom tyrosinase inhibition rate of a freeze-dried sample of a bird's nest hydrolysate containing the polypeptide is determined and calculated.
[0097] Table 2:
[0098]
[0099] The mixture was placed in a water bath at 28°C for 10 minutes, and the absorbance at 475 nm was measured using an enzyme marker. The mushroom tyrosinase inhibition rate of the freeze-dried sample of the bird's nest hydrolysate containing the polypeptide was calculated according to Formula 3:
[0100]
[0101] in,
[0102] A1 is the absorbance value of control group A1 at 475 nm;
[0103] A2 is the absorbance value of control group A2 at 475 nm;
[0104] A3 is the absorbance value of control group A3 at 475 nm;
[0105] A4 is the absorbance value of the sample A4 to be tested at 475 nm.
[0106] Gel permeation chromatography (GPC) is the best method to characterize the complete molecular weight distribution of polymers, and the molecular weight distribution measured by GPC is considered to be a relevant physical property evaluation index. In the embodiments and comparative examples of the present invention, gel permeation chromatography (GPC) was used to determine the molecular weight distribution of the bird's nest enzymatic hydrolyzate.
[0107] The scheme of the present invention will be explained below in conjunction with the embodiments. It will be appreciated by those skilled in the art that the following embodiments are only used to illustrate the present invention and should not be considered as limiting the scope of the present invention. Where specific techniques or conditions are not indicated in the embodiments, the techniques or conditions described in the literature in this area or the product specifications are used. The reagents or instruments used are not indicated by the manufacturer and are all conventional products that can be obtained commercially.
[0108] Example 1: Preparation of freeze-dried samples of bird's nest enzymatic hydrolysate
[0109] Pretreatment: After the dry bird's nest is crushed and sieved with a 100-mesh screen, the bird's nest is soaked in distilled water for 2 hours at a mass ratio of 50:1, and then stewed at 120°C for 2 hours, and then homogenized with a colloid mill. The grinding gap of the colloid mill is 50μm, and the grinding time is 20min to obtain the bird's nest homogenate to be treated.
[0110] Pulse electric field treatment: The homogenate of the bird's nest to be treated is pumped to the high-voltage pulse electric field treatment chamber for pulse electric field treatment; after the pulse electric field treatment is completed, the material is collected to obtain the bird's nest solution to be enzymatically hydrolyzed. The conditions for pulse electric field treatment are: the electric field strength in the high-voltage pulse electric field treatment chamber is 15kv / cm, the pulse width is 3μs, the frequency is 150Hz, the flow rate is 300kg / h, and the treatment time is 60s.
[0111] Enzyme treatment: add 20000U alkaline protease (U / g) to the bird's nest hydrolyzate obtained after the pulse electric field treatment, place it in a 55°C constant temperature oscillator for enzymolysis for 60 minutes, and use 1 mol / L sodium hydroxide to always maintain the enzymolysis product at a constant pH of 8.0; then place it in boiling water at 100°C to inactivate the enzyme for 15 minutes, cool to room temperature, centrifuge for 10 minutes, rotate at 10000rpm / min, and at -4°C to obtain a bird's nest hydrolyzate containing the polypeptide, the main component of which is the bird's nest polypeptide;
[0112] Post-treatment: filtering, concentrating and freeze-drying the bird's nest hydrolysate to obtain a freeze-dried sample of the bird's nest hydrolysate containing the polypeptide. The specific method is: using a 100nm ceramic membrane to desalt and concentrate the bird's nest hydrolysate obtained by enzyme treatment to obtain a ceramic membrane concentrate, wherein the operating pressure of the desalting and concentration is 4 bar and the temperature is 80°C. Freeze-drying the ceramic membrane concentrate to obtain a freeze-dried sample of the bird's nest hydrolysate containing the polypeptide, the main component of which is the bird's nest polypeptide.
[0113] Examples 2 to 26, Comparative Examples 1 to 4: Screening of Preparation Conditions for Freeze-dried Samples of Bird's Nest Hydrolysates Containing the Peptide
[0114] In Examples 2 to 26, the inventors further investigated the effects of the colloid mill tooth gap, grinding time, specific parameters of the high-voltage pulse electric field (field strength, pulse width, frequency, flow rate, processing time), enzyme type, addition amount, enzymolysis temperature and time on the quality of freeze-dried samples of bird's nest enzymatic hydrolysis products.
[0115] Compared with Example 1, the differences in the preparation methods of the freeze-dried samples of the bird's nest enzymatic hydrolysate containing the polypeptide in Examples 2 to 26 and Comparative Examples 1 to 4 are shown in Table 3. (Taking Example 1 as a reference standard, "—" in Table 3 represents that the processing conditions in this step are exactly the same as those in Example 1, and "colloid mill tooth gap 40 μm" etc. are the changed condition parameters of this example):
[0116] Table 3
[0117]
[0118]
[0119] Note: “—” represents that the processing conditions of this step are exactly the same as those in Example 1; the text part describes the differences between the corresponding processing conditions of this step and those in Example 1.
[0120] The results of the hydrolysis degree investigation of the freeze-dried samples of bird's nest enzymatic hydrolysates obtained in Examples 1 to 26 and Comparative Examples 1 to 4 are shown in Figure 1 The results of protein recovery rate are shown in Figure 2 The results of the investigation on DPPH free radical scavenging ability are shown in Figure 3 The results of the investigation on mushroom tyrosinase inhibition rate are shown in Figure 4 .
[0121] The results show that:
[0122] (1) At the same concentration, compared with Comparative Examples 1 to 4, the lyophilized samples of bird's nest enzymatic hydrolysates prepared in Examples 1 to 26 of the present invention have significantly improved hydrolysis degree and protein recovery rate. This is conducive to improving the extraction efficiency of active ingredients and increasing the nutritional value of the product ( Figure 1 , Figure 2). When the bird's nest is only subjected to the methods of Comparative Examples 1 to 4 or the colloid mill treatment, pulse treatment, enzymatic treatment and ceramic membrane concentration parameters are not within the range of Examples 1 to 26 of the present invention, the hydrolysis degree and protein recovery rate of the obtained bird's nest enzymatic hydrolysis product are low, which is not conducive to extracting the antioxidant active ingredients in the bird's nest.
[0123] (2) At the same concentration, compared with Comparative Examples 1 to 4, the freeze-dried samples of bird's nest enzymatic hydrolysates prepared in Examples 1 to 26 of the present invention have significantly improved DPPH free radical scavenging rates and have good antioxidant effects ( Figure 3 ). When the bird's nest is only subjected to the methods of Comparative Examples 1 to 4 or the parameters of colloid mill treatment, pulse treatment, enzymatic treatment and ceramic membrane concentration are not within the range of Examples 1 to 26 of the present invention, the DPPH free radical scavenging ability of the obtained bird's nest enzymatic hydrolysis product is poor, which is not conducive to the effective extraction of the antioxidant active ingredients in the bird's nest.
[0124] (3) At the same concentration, compared with Comparative Examples 1 to 4, the freeze-dried samples of the bird's nest enzymatic hydrolysates prepared in Examples 1 to 26 of the present invention have significantly improved tyrosinase inhibitory activity and have good anti-aging effects ( Figure 4 When the bird's nest is only processed by the methods of Comparative Examples 1 to 4 or the parameters of colloid mill treatment, pulse treatment, enzymatic treatment and ceramic membrane concentration are not within the range of Examples 1 to 26 of the present invention, the tyrosinase inhibition activity of the obtained bird's nest enzymatic hydrolysis product is poor, which is not conducive to the effective extraction of the anti-aging active ingredients in the bird's nest.
[0125] Evaluation of the efficacy of the bird's nest enzymatic hydrolysate of the present invention
[0126] Further, the inventors, with reference to Example 1, investigated the molecular weight distribution, hygroscopicity, moisturizing ability, cell viability, FLG expression level, protection against UVB cell damage, repair of cell scratches, and repair of animal skin damage of three bird's nest enzymatic hydrolyzates prepared by the same process. The specific experimental methods and experimental results are as follows:
[0127] 1. Molecular weight distribution of bird's nest enzymatic hydrolysis products
[0128] Molecular weight determination method: The conditions used for molecular weight determination are the gel permeation chromatography method in the national recommended standard "GB / T22729-2008 Marine Oligopeptides". The separation column used is TSK Gel G2000 SWXI, the mobile phase is 45% (W / V) acetonitrile aqueous solution (containing 0.1% trifluoroacetic acid), the flow rate is 0.5mL / min, and the detection wavelength is 214nm. The standards used are a series of protein or polypeptide samples with known molecular weights: cytochrome C (12384Da), aprotinin (6511Da), bacitracin (1450Da), oxidized glutathione (651Da) and Gly-Gly-Gly (189Da). The standard curve equation of molecular weight and retention time is: y=31.94-4.443log(x), where the correlation coefficient R 2 =0.9766, y represents the retention time, in min; x represents the molecular weight, in Da. According to the standard curve, the distribution ratios of peptides with different molecular weights in three portions of bird's nest enzymatic hydrolyzate containing the polypeptide are calculated by area normalization method.
[0129] The molecular weight distribution of bird's nest enzymatic hydrolysis products is shown in Figure 5 , Figure 6 .
[0130] The experimental results show that: GPC analysis results show that the molecular weight distribution patterns of the three batches of bird's nest enzymatic hydrolysates show a high degree of overlap ( Figure 5 ); Quantitative analysis showed that the bird's nest peptides in the enzymatic hydrolysis products were mainly low molecular weight (0.1-3 kDa) polypeptides, accounting for 87.1±0.57% ( Figure 6 ).
[0131] The above results show that: the proportion of low molecular weight polypeptides in the bird's nest enzymatic hydrolysate of the present invention is high, and the method for preparing the bird's nest enzymatic hydrolysate of the present invention has good repeatability.
[0132] 2. Hygroscopicity, moisturizing capacity and cytotoxicity of bird's nest enzymatic hydrolysates and their effects on FLG expression levels
[0133] (1) Hygroscopicity of bird’s nest enzymatic hydrolysis products
[0134] Method for determining moisture absorption rate: 200 μg of freeze-dried sample of bird's nest enzymatic hydrolysate was accurately weighed into a constant weight weighing bottle with a diameter of 50 mm. A saturated mixed solution of water, glycerol (1:3, v / v) and sodium chloride (1wt%) can maintain an ambient relative humidity (RH) of 56%. A certain mass of saturated mixed solution was prepared and placed in a sealed desiccator. The freeze-dried sample of bird's nest enzymatic hydrolysate was placed in a dryer containing a saturated solution at 30°C for 48 hours, and the weight of the sample powder and glass dish was measured after 24 hours. The moisture absorption rate (%) of the sample (n=3) was calculated to determine the moisture absorption capacity of the bird's nest enzymatic hydrolysate.
[0135] (2) Moisturizing ability of bird’s nest enzymatic hydrolysate
[0136] Method for determining water loss rate: 200 μg of freeze-dried sample of bird's nest enzymatic hydrolysate containing the polypeptide is accurately weighed into three parts and placed in a glass constant weight weighing bottle (30 mm in diameter). 2 mL of distilled water is added to the glass constant weight weighing bottle to a final concentration of 10%, and then placed in a dry container containing a saturated calcium chloride solution (30 ± 1°C, relative humidity 32 ± 1%) and soaked for 48 hours. After 24 hours, the mass of the three samples (n = 3) and the weight of the glass dish are recorded. The three groups of samples are weighted and the water loss rate (i.e., water loss rate) (%) is calculated to determine the moisturizing ability of the bird's nest enzymatic hydrolysate.
[0137] (3) Cytotoxicity of bird's nest enzymatic hydrolysis products
[0138] In cell experiments, cell survival rate will affect the experimental results, and it is necessary to determine the safe addition concentration of each substance in the cell experiment through toxicity experiments in advance.
[0139] The MTT method was used to detect the effect of bird's nest enzymatic hydrolysate on HaCat cell viability. The investigation method was as follows: 1×10 4 HaCat cells were inoculated into 96-well plates at a cell density of 100 μL / mL, and the plates were incubated at 37°C and 5% CO. 2 The cells were cultured in an incubator for 24 h to allow the cells to completely adhere to the wall. The culture medium was removed, the cells were washed twice with PBS buffer, and different concentrations of bird's nest enzymatic hydrolyzate solutions containing the polypeptide (0, 1, 10, 100, 1000 and 10000 μg / mL) prepared with MEM were added and incubated at 37°C and 5% CO 2 Incubate in the incubator for 24 h. After the incubation, add 20 μL of MTT solution to each well, continue incubation for 4 h, and then use a microplate reader to detect the absorbance at 570 nm.
[0140] (4) Effect of bird's nest enzymatic hydrolysis products on FLG expression levels in HaCat cells
[0141] The investigation method is as follows: HaCat cells in the logarithmic growth phase were cultured at 1×10 6 The cells were seeded at a density of 100 / mL in a 6-well plate and placed in a 37°C, 5% CO 2The cells were cultured in an incubator for 24 h, the culture medium was removed, and the cells were washed twice with PBS buffer. Different concentrations of bird's nest enzymatic hydrolyzate solution (1, 100, 1000 μg / mL) prepared by MEM were added to treat the cells for 1 h. The cells were collected, suspended with Trizol reagent, and total RNA was extracted. According to the instructions of the reverse transcription kit, each sample was reversely transcribed to synthesize cDNA. The QuantStudioTM 1Plus fluorescent quantitative PCR instrument was used for detection. The synthetic primers were designed by Sangon Biotech (Shanghai) Co., Ltd. The nucleotide sequences of the primers are as follows:
[0142] FLG forward: 5'-CTGTGGTCATTCATGGAGTGG-3'
[0143] Reverse: 5'-CCCTAGAAGGGCTAATGTGTGA-3'
[0144] GAPDH: forward: 5'-GCACCGTCAAGGCTGAGAAC-3'
[0145] Reverse: 5'-TGGTGAAGACGC CAGTGGA-3'
[0146] Each sample was repeated 3 times (n=3), and GAPDH gene was used as internal control. -△△CT Methods The results were calculated and graphed using Graph Pad Prism Program software. t-test was used for statistical analysis among the groups. p<0.05 indicated a significant difference, and p<0.01 indicated an extremely significant difference.
[0147] (5) Protective effect of bird's nest enzymatic hydrolysis products on skin damage
[0148] Establishment of UVB radiation-induced cell injury model: HaCat cells were cultured in DMEM containing 10% FBS (fetal bovine serum) and 1% penicillin / streptomycin and placed in a 5% CO 2 , 37°C in a carbon dioxide incubator. HaCaT cells growing in logarithmic phase were plated in 96-well plates at a cell density of 3×10 4 After overnight attachment, the cell culture plate was irradiated at a distance of 15 cm from the UV lamp for 0, 0.5 h, 1 h, 1.5 h, 2 h, 3 h, 4 h, 5 h, and 6 h (irradiation dose 5 J / cm 2 ) to cause cell damage, and the blank control group was covered with tin foil to block ultraviolet radiation (n=6).
[0149] EdU cell proliferation assay was used to detect the cell proliferation activity of cells damaged by UVB after the enzymatic hydrolysate of bird's nest was used. The specific method was as follows: cells were plated in a 96-well plate at 1×10 4Each well was inoculated with 100 μL of culture medium and placed at 37°C with 5% CO 2 Culture in an incubator for 24 h to allow cells to fully adhere to the wall. UVB (5J / cm 2 ) for 90 min, treated with different concentrations of bird's nest enzymatic hydrolysate solution (0, 1, 100, 1000 μg / mL) or Vc, and a blank control group was set up. According to the instructions of the EdU kit, thymine analog EdU was added to the culture medium at a final concentration of 10 μM for 2 h before terminating the culture. After incubation, the cells were fixed in 4% paraformaldehyde (PFA) solution for 15 min and permeabilized with 0.1% Triton X-100. After washing with 3×5 min of rinsing buffer, the cells were incubated with EdU at room temperature for 30 min. After rinsing with rinsing buffer for 3×5 min, they were rinsed with Hoechst 33342 stain (5 μg / mL) in PBS for 10 min. After rinsing, PBS was added and stored at 4°C in the dark. Cells were captured with a 10x objective under an inverted fluorescence microscope for EdU signal imaging and quantification. The composite images were analyzed by ImageJ software.
[0150] During wound healing, cells need to proliferate and migrate to the wound. The migration phase is the rate-limiting event of wound healing. Therefore, the test for evaluating cell migration is very useful in in vitro wound healing analysis, and can screen and identify active compounds. In the embodiment of the present invention, the ability of the bird's nest enzymatic hydrolysate of the present invention to promote wound healing was explored by an in vitro scratch experiment of "scratching" on a HaCat monolayer of cells. The specific investigation method is as follows:
[0151] HaCat cells were cultured at 1×10 6 The cells were inoculated at a density of 100 μg / mL in a 6-well plate, with 2 mL in each well, and placed in a 37°C, 5% CO2 incubator for 24 hours to allow the cells to fully adhere to the wall. A horizontal reference line was made with a marker pen on the bottom of the plate, and the grid was used for alignment to obtain the same area for each image acquisition run. Then, a pipette tip was used to make cell scratches in the cell culture plate, the culture medium was removed, and the PBS buffer was washed twice. Different concentrations of bird's nest enzymatic hydrolysate solution (0, 1, 100, 1000 μg / mL) or 1000 μg / mL Vc sample solution (n=5) prepared by MEM were added, and photos were taken. Then, it was placed in a 37°C, 5% CO2 incubator for incubation, and images were collected at 0, 6, 12, 20, 24, and 48 hours, respectively. The collected images were quantitatively analyzed using ImageJ software, and the software was used to quantitatively analyze indicators such as the percentage of wound healing area and scratch healing rate at each time point.
[0152] The results of the investigation on the hygroscopicity of bird's nest enzymatic hydrolysate are shown in Figure 7 The results of the investigation on the moisturizing ability of bird's nest enzymatic hydrolysate are shown in Figure 8, Cell viability test The effect of bird's nest enzymatic hydrolysate on HaCat cell viability Fig. 9 The results of the study on the effect of bird's nest enzymatic hydrolysate on the expression level of FLG in HaCat cells are shown in Fig.10 The results of the investigation on the protective effect of bird's nest enzymatic hydrolysate on skin damage are shown in Fig.11 , Fig.12 , Fig.13 , Fig.14 .
[0153] The experimental results show:
[0154] (1) Water plays an important role in protecting the skin from external influences. The skin's ability to retain water, i.e., skin moisturizing ability, is one of the key factors for skin health.
[0155] After exposure to 30℃ and 56% relative humidity for 24h and 48h, the weight of the enzymatic hydrolysate of bird's nest increased by 0.17% and 0.19% respectively ( Figure 7 , p>0.05). Under the same conditions, materials with an absorption rate of less than 1% are considered non-hygroscopic. 56% RH has the least morphological stress on the bird's nest enzymatic hydrolysate and the best stability. Therefore, the bird's nest enzymatic hydrolysate of the present invention has low hygroscopicity, which is beneficial to maintaining the stability and quality control of the product and helps to maintain the consistency of the morphology of the freeze-dried powder of the bird's nest enzymatic hydrolysate.
[0156] After exposure to 32% relative humidity and 30°C for 24 h and 48 h, the moisture content of the enzymatic hydrolysate of bird's nest decreased by 1.43% and 2.69%, respectively ( Figure 8 , p>0.05). Thus, the water content of the bird's nest enzymatic hydrolysate of the present invention is further reduced under low humidity conditions, further enhancing its stability, reducing corruption, facilitating storage, transportation and handling, reducing the risk of product damage caused by humidity changes, helping to maintain the appearance and structural integrity of the product, and helping to maintain the biological activity of the polypeptide.
[0157] (2) The survival rate of HaCat cells exceeded 90% when the concentration of bird's nest enzymatic hydrolysate was within the range of 10-1000 μg / mL ( Fig. 9 ). The results show that: within the concentration range of 10-1000μg / mL, the enzymatic hydrolysate of bird's nest has no cytotoxicity to HaCat cells, which is a safe concentration for cell experiments.
[0158] (3) Compared with the blank control group, there was no significant difference in the relative expression of FLG when the concentration of bird's nest enzymatic hydrolysate was 1 μg / mL and 100 μg / mL (p>0.05), but at 1000 μg / mL, the relative expression of FLG increased significantly (p<0.05) ( Fig.10 ).
[0159] The above results show that the enzymatic hydrolysate of the bird's nest of the present invention has moderate moisture retention and the ability to promote FLG expression.
[0160] (4) As the UVB damage time prolonged, the cell viability of HaCat cells showed a significant gradient downward trend. Starting from 1.5 h after the damage, the cell viability of HaCat cells was significantly reduced compared with the blank group (p < 0.01), and the cell viability of HaCat cells decreased to about 60% of that of the blank group ( Fig.11 , Fig.12 The results showed that after irradiation of HaCat cells with UVB for 1.5 hours, cell viability was significantly reduced, cell damage was significant, and the cell damage model was successfully established.
[0161] Compared with the blank control group (100.00±2.25%), UV (UVB irradiation intensity 5J / cm 2 The survival rate of HaCat cells in the irradiated model group (without intervention with bird's nest enzymatic hydrolysate) was significantly decreased (67.06±3.80%, p<0.001, Fig.13 C), the difference was statistically significant; compared with the blank control group and Vc (positive control) group, the survival rate of HaCat cells increased significantly after the bird's nest enzymatic hydrolysate treated the UVB damaged cells for 24 hours ( Fig.13 A. Fig.13 B); When the concentration of bird's nest enzymatic hydrolysate was 1000 μg / mL, the survival rate of HaCat cells increased significantly (91.64±4.61%, p<0.05, Fig.13 C) and return to normal cell morphology ( Fig.13 B).
[0162] Compared with the UV irradiation model group, the blank control group had a larger proportion of HaCat cells in the proliferation phase (red fluorescence) (13D). The proportion of HaCat cells in the S phase in the UVB irradiation group (9.23±1.51%) was significantly lower than that in the control group (50.48±4.08%, p<0.0001, Fig.13 E). Compared with the UV irradiation model group, the proportion of HaCat cells in the S phase of proliferation was significantly increased in the Vc (positive control) group and the bird's nest enzymatic hydrolysate treatment group (p<0.05). In the group treated with the highest concentration of bird's nest enzymatic hydrolysate, the number of HaCat cells positively stained with EdU was very close to that of the blank control group.
[0163] The above results show that: the enzymatic hydrolysate of the bird's nest of the present invention has good activity in promoting cell proliferation and is concentration-dependent; and has strong anti-photoaging (ultraviolet induced) ability.
[0164] (5) The group treated with the enzymatically hydrolyzed product of bird's nest and the Vc (positive control) group showed the ability to promote the healing of scratched epidermal cells in vitro ( Fig.14 A); compared with the model group (Model) and the group treated with low-concentration enzymatically hydrolyzed product of bird's nest (1 μg / mL), the wound healing rate of the Vc group (positive control) and the groups treated with high-concentration enzymatically hydrolyzed product of bird's nest (100 and 1000 μg / mL) was faster ( Fig.14 B, Fig.14 C).
[0165] The percentages of wound healing area of the model group (Model), Vc group (positive control), and the groups treated with enzymatically hydrolyzed product of bird's nest (1 μg / mL, 100 μg / mL, 1000 μg / mL) after 48 h were 48.13%, 59.87%, 46.45%, 71.84%, and 70.33% respectively ( Fig.14 B); compared with the blank control group (6.09 ± 2.31%, p < 0.01, Fig.14 C), the scratch healing rates of each experimental group after 6 h showed that the wound scratch area exposed to the high-concentration enzymatically hydrolyzed product of bird's nest group was significantly reduced (24.84 ± 1.91%, p < 0.01, Fig.14 C).
[0166] The above results indicate that the enzymatically hydrolyzed product of bird's nest of the present invention has the ability to promote the migration and proliferation of HaCaT cells in wound healing.
[0167] 3. Investigation on the skin repair effect of the enzymatically hydrolyzed product of bird's nest on mice
[0168] Using 30% glycolic acid (GA) as a chemical inducer to cause skin damage in mice, and exploring the skin repair effect of the main component of the enzymatically hydrolyzed product of bird's nest, bird's nest polypeptide.
[0169] The specific method is as follows:
[0170] SPF-grade C57BL / 6J mice, 6 - 7 weeks old, female (n = 8) were selected. The mice were purchased from the Guangdong Provincial Medical Experimental Animal Center (No. 44007200103100, SCXK (Guangdong) - 2022 - 0002). After 2 weeks of quarantine, the experiment began. After anesthetizing the mice, depilation treatment was carried out on the mice with depilatory cream, the depilatory cream was washed off and the back skin of the mice was cleaned with 70% alcohol, and the back skin was divided into 2 quadrants. The mice were randomly grouped and the experiment began after 24 h of adaptive feeding.
[0171] Establish a chemical stimulation injury model: Prepare a 30% fruit acid (glycolic acid) solution, apply it evenly to the skin of the mice, keep it for 30 min, then wash the back skin of the mice, and compare the skin changes of the mice before and after.
[0172] After glycolic acid injury, the mouse skin was divided into two quadrants, one quadrant was smeared with saline as the control group, and the remaining areas were smeared with vitamin C (1000μg / mL, n=3), HA (0.02%, n=3) and bird's nest enzymatic hydrolysate (100μg / mL, n=3). Different drugs were applied to the injured skin of mice 3 times a day, with an intervention interval of 6h for 7 days. During the experiment, the skin condition of the back of the mice was observed and photographed, and the changes in the wound area were analyzed using ImageJ software.
[0173] On the 8th day, the mice were anesthetized with 2% sodium pentobarbital, and the skin tissues of mice in each group were taken for HE staining, and some skin tissues were frozen in a -80 °C refrigerator for testing. All operations were performed at the Laboratory Animal Research Institute of Qingyuan People's Hospital in accordance with the institutional guidelines of the same institution (Permit No.: LAEC-2022-009).
[0174] The results of the investigation on the skin repair effect of bird's nest enzymatic hydrolysate on mice are shown in Fig.15 .
[0175] The experimental results show:
[0176] (1) Compared with the left side, 30 minutes after applying 30% (w / v) glycolic acid, the skin became red and swollen, with a burning sensation, blisters, and even ulcers and necrosis. The animal model of skin injury was successfully established ( Fig.15 A).
[0177] (2) Continuous application of bird's nest enzymatic hydrolysate (100 μg / mL) for 7 days can effectively promote the repair of glycolic acid-induced skin burn areas (right, Fig.15 B); Compared with the Vc group (positive control) and the HA group (positive control), the repair effect of the skin burn area treated with bird's nest enzymatic hydrolysate (100 μg / mL) was stronger.
[0178] (3) HE staining results showed that compared with the Vc group (positive control) and the HA group (positive control), the epidermis of the skin burn area in the bird's nest enzymatic hydrolysate group (100 μg / mL) was smooth and well-layered ( Fig.15 C), the skin repair effect is obvious.
[0179] The above results show that the enzymatic hydrolysate of the bird's nest of the present invention can effectively promote the repair of burn skin induced by glycolic acid in mice.
[0180] Identification and screening of bioactive peptide sequences
[0181] Furthermore, the inventors conducted sequence identification and screening of bioactive peptides in the enzymatic hydrolysate of the bird's nest of the present invention. Specifically, the process includes: determination of the amino acid composition of the enzymatic hydrolysate of the bird's nest, identification of the sequence of bioactive peptides and virtual screening of active peptides. The specific experimental methods and experimental results are as follows:
[0182] 1. Determination of amino acid composition of bird's nest enzymatic hydrolysis products
[0183] Hydrochloric acid method for pretreatment of amino acids: Accurately pipette 15 mg of bird's nest enzymatic hydrolysis product, carefully add it to a thick glass tube, try to prevent it from sticking to the wall, then carefully add 10 mL of 6 mol / L hydrochloric acid in a 1:1 ratio. If there is sample sticking to the bottle wall, it can be washed off with hydrochloric acid. The amount of hydrochloric acid does not need to be accurately weighed. Add 3-4 drops of phenol, freeze with liquid nitrogen for 3 minutes, repeat nitrogen blowing-vacuuming 3 times, tighten the bottle cap, and place it in a 110℃ oven for hydrolysis for 22 hours.
[0184] Sample filtration and volume adjustment: Filter the hydrolyzed sample with filter paper into a 25 mL volumetric flask, wash the filter paper three times, and finally adjust the solution to the 25 mL mark.
[0185] Sample deacidification: Pipette 1 mL of solution into a drying dish and dry it in an oven at 60°C. After drying, add water to dissolve it and repeat the drying twice until only solid traces remain.
[0186] Sample detection: Pipette 2mL of 0.02mol / L dilute hydrochloric acid to dissolve the deacidified sample, filter it into the injection bottle for chromatographic analysis through a 0.22μm filter head, and detect it on the machine.
[0187] Amino acid automatic analyzer system: the chromatographic column is membra Pure T259 sodium ion exchange column; the mobile phase is gradient elution with a flow rate of 160 μL / min; the ninhydrin post-column derivatization is performed with a flow rate of 80 μL / min; the injection volume is 20 μL, and detection is performed using a 570 nm and 440 nm dual-channel visible light photometer.
[0188] The results of amino acid composition determination of bird's nest enzymatic hydrolysate are shown in Fig.16 .
[0189] The experimental results show that: (1) The amino acid separation of 17 standard amino acids (Asp, Ala, Thr, Cys, Ser, Val, Glu, Met, Gly, Ile, Pro, Arg, Leu, His, Lys, Phe and Tyr) in the bird's nest hydrolysate of the present invention has achieved good peak and baseline separation shapes. The chromatographic retention time of the amino acids in the bird's nest hydrolysate of the present invention is similar to the standard curve, indicating that the amino acid composition in the bird's nest hydrolysate of the present invention is diverse. (2) The bird's nest hydrolysate of the present invention is rich in serine (10.97%) and rich in N-terminal amino acids such as glycine (9.15%) and leucine (8.28%).
[0190] 2. Sequence identification and screening of bioactive peptides from bird's nest enzymatic hydrolysis products
[0191] Sample preparation: The enzymatic hydrolysate of the bird's nest was passed through a 10KDa ultrafiltration membrane and desalted before mass spectrometry detection.
[0192] Chromatographic separation: Liquid A used in the liquid phase is 0.1% formic acid aqueous solution, and liquid B is 0.1% formic acid acetonitrile aqueous solution (acetonitrile is 84%).
[0193] The liquid chromatography column (0.15 mm*150 mm, RP-C18, Column Technology Inc.) was equilibrated with 95% A solution, and the sample was loaded into Zorbax 300SB-C18 peptide traps (Agilent Technologies, Wilmington, DE) by an automatic sampler and then separated by the liquid chromatography column. The relevant liquid phase gradient was set as follows:
[0194] 0 min - 50 min, linear gradient of solution B from 4% to 50%;
[0195] 50-54 minutes, linear gradient of solution B from 50% to 100%;
[0196] 54 minutes---60 minutes, liquid B was maintained at 100%.
[0197] Mass spectrometry identification: The enzymatic hydrolysate of bird's nest was separated by capillary high performance liquid chromatography and then analyzed by mass spectrometry using a Q Exactive mass spectrometer (Thermo Fisher). The analysis time was 60 min. Detection method: positive ion. The mass-to-charge ratio of the polypeptide and polypeptide fragments was collected according to the following method: 10 fragment spectra (MS2 scan) were collected after each full scan to determine the bird's nest peptide sequence in the enzymatic hydrolysate of bird's nest.
[0198] Virtual screening of active peptides: Molecular docking studies were performed using AutoDockTools (ADT). The 20 amino acids, amino acid repeats and peptides in the bird's nest peptide were docked with the active site of the proton-dependent oligopeptide transporter PepT1 (PDB ID: 4D2C) using the AutoDockVina standard program. The ligand structure model was constructed and optimized using ChemDraw and ADT software. The grid frame was constructed using 15.0, 15.0, and 30.0, pointing to the x, y, and z directions, with a grid point spacing of The center grid box is and Scoring function weights and terms were set to default values. Post-docking analysis was performed using AutoDock Tools and PyMOL. The conformation with the most favorable (lowest) free binding energy was selected and the interaction between the target receptor and the ligand was analyzed using PyMOL.
[0199] The results of identification of bioactive peptide sequences and screening of active peptides from bird's nest enzymatic hydrolysis products are shown in Fig.17 , Fig.18 , Table 4 , Table 5 , Table 6. These data were collected by considering the peptide amino acid repeats, the N-terminal and C-terminal amino acid composition, and the length of the peptide sequence.
[0200] Table 4: Binding affinity of 20 amino acids and their repeat fragments to PepT1
[0201]
[0202]
[0203] Table 5: Peptides containing amino acid repeating sequences in bird's nest enzymatic hydrolysis products bird's nest peptides
[0204]
[0205]
[0206]
[0207]
[0208] Table 6: Binding affinity of 17 bird's nest peptides to PepT1
[0209]
[0210]
[0211] The above results show that:
[0212] (1) When the binding energy (Docking score) of the binding affinity between the peptide and PepT1 is less than -7 kcal / mol, it is generally considered that the binding effect is very strong. In order to accurately and effectively find the specific peptide sequences in the bird's nest hydrolysate that are easy to strongly bind to the transporter PepT1, Autodock Vina was first used to calculate the binding affinity of 20 amino acids and their repeated fragments with PepT1. The binding energy was less than -5 kcal / mol, indicating good binding. Further results showed that hydrophobic amino acids (including Trp, Ala, Phe and Tyr) showed good binding with the highest predicted affinity ( Fig.17 The Vina scores of amino acid repeat sequences of Trp, Phe and Tyr, including AA (-8.7, -9.1 and -9.2 kcal / mol) and AAA (-9.3, -8.4 and -9.6 kcal / mol), are significantly higher than those of single amino acids (-6.9, -6.2 and -6.8 kcal / mol). The above results suggest that continuous sequences of the same amino acids have a strong interaction with the receptor PepT1 (Table 4). The polypeptides containing amino acid repeat sequences in the bird's nest hydrolyzate bird's nest peptide of the present invention are shown in Table 5.
[0213] (2) The binding of dipeptides to PepT1 is sensitive to the N-terminal residue. Hydrophobic amino acids are the preferred substrates of oligopeptide transporters (PepT1 and PepT2), and hydrophobic amino acids are the most common amino acid residues at the N-terminus. The inventors speculated that if both side chains are hydrophobic acids, bird's nest peptides rich in hydrophobic amino acids have the highest predicted affinity. To verify this predictive ability, the inventors calculated the binding affinities of 17 different peptides from bird's nest peptides to PepT1 (Table 6). The docking Vina scoring results showed that the three 3-peptide sequences with the highest Vina scores in bird's nest peptides were YFF, WFF and WWP ( Fig.18 ), which indicates that they bind strongly to PepT1 and are easily transported by the transporter and absorbed into the skin tissue. In addition, there are conventional hydrogen bonds, pi-pi bonds, or hydrophobic interactions between peptides YFF, WFF, and WWP and PepT1, suggesting that they may play an important role in the peptide translocation function of PepT1.
[0214] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0215] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.
Claims
1. A polypeptide, It is characterized in that include: YY, FF, WW, AA or GG amino acid repeat sequence; The polypeptide has 3 to 8 amino acid residues.
2. The polypeptide according to claim 1, It is characterized in that The number of amino acid residues in the polypeptide is 3; Further, the amino acid sequence of the polypeptide is as shown in any one of WWT, WWL, WWF, WWP, WWS, WWW, AYY, MYY, WYY, YYF, YYS, YYE, TYY, YYC, YYQ, YYY, AFF, FFL, TFF, FFH, QFF, MFF, FFW, FFR, NFF, FFF, FFW, WWP, and WWS; Optionally, the number of amino acid residues in the polypeptide is 4; Further, the amino acid sequence of the polypeptide is as shown in any one of EAYY, YFYY, VFYY, YYVL, YYLL, YYYS, FAYY, YYGQ, YYNL, YYTA, FFLE, KVFF, LAFF, FFEL, FFSE, VFFL, FFGF, FFSY, FFTK, VFFG, VGFF, FFPA, FFTL, SRFF, FFCH, LAAF, LAAW, LAAL, YAAL, FAAR, RAAF, PGGF, and WGGF; Optionally, the number of amino acid residues in the polypeptide is 5; Further, the amino acid sequence of the polypeptide is shown in any one of YYSGQ, VTFFH, VAAGL, GFLAA, VAALL, YAATL, PAAQF, WAAQ, and LAPAA; Optionally, the number of amino acid residues in the polypeptide is 8; Furthermore, the amino acid sequence of the polypeptide is shown in any one of FDLMYYPY, GAAPCPRD, VGTREAAF, SPGGHQIL, FGGNPGGF, FDLMNGGP, PRPAGGPI, and TGGAGPHW.
3. The polypeptide according to claim 2, It is characterized in that The N-terminus and C-terminus of the polypeptide are hydrophobic amino acid residues; Optionally, the hydrophobic amino acid residue is selected from F, Y, W, L, I, V, A, P, G, M, C, S, T; Furthermore, the amino acid sequence of the polypeptide is shown in any one of WWL, WWP, WWS, WWW, YYF, YYY, and FFL.
4. The polypeptide according to any one of claims 1 to 3, It is characterized in that The polypeptide is derived from bird's nest.
5. A method for preparing a bird's nest enzymatic hydrolyzate comprising the polypeptide according to any one of items 1 to 4, It is characterized in that The steps include: (1) heating the bird's nest and then subjecting it to a colloid mill to obtain a bird's nest homogenate; (2) subjecting the bird's nest homogenate to a pulse electric field treatment to obtain a bird's nest solution to be enzymatically hydrolyzed; (3) subjecting the bird's nest to be hydrolyzed to enzymatic hydrolysis to obtain a bird's nest enzymatic hydrolyzate; (4) The bird's nest enzymatic hydrolysate is concentrated by a ceramic membrane, and the concentrated solution is collected to obtain the bird's nest enzymatic hydrolysate.
6. The method according to claim 5, It is characterized in that In the colloid mill treatment, the grinding gap of the colloid mill is 30 to 70 μm, preferably 40 to 60 μm; the grinding time is 10 to 120 min, preferably 10 to 30 min; Optionally, the pulse electric field treatment comprises: passing the bird's nest homogenate through a pulse electric field treatment chamber for pulse electric field treatment; the electric field strength of the pulse electric field treatment chamber is 10 to 150 kv / cm, the pulse width is 1 to 5 μs, the frequency is 100 to 300 Hz, the time for the bird's nest homogenate to pass through the pulse electric field treatment chamber is 30 to 90 s, and the flow rate is 200 to 400 kg / h; Optionally, the step (3) comprises: contacting the bird's nest hydrolyzate with alkaline protease or alkaline protease combined with pancreatic enzyme to perform enzymatic hydrolysis to obtain the bird's nest hydrolyzate; Furthermore, 15000-25000U of the alkaline protease or alkaline protease combined with pancreatic enzyme is added to each gram of the bird's nest to be enzymatically hydrolyzed; Furthermore, the alkaline protease or alkaline protease combined with pancreatic enzyme comprises at least one of alkaline protease, flavor alkaline protease, alkaline protease combined with pancreatic enzyme, and flavor alkaline protease combined with pancreatic enzyme; Furthermore, the temperature of the enzymatic hydrolysis treatment is 50-60°C and the time is 40-80min; Optionally, the ceramic membrane concentration treatment comprises: desalting and concentrating the bird's nest enzymatic hydrolysate through a ceramic membrane, wherein the pore size of the ceramic membrane is 50 to 100 nm.
7. The method according to claim 5, It is characterized in that Also includes: The bird's nest enzymatic hydrolysis product is freeze-dried to obtain a bird's nest enzymatic hydrolysis dried product.
8. A bird's nest enzymatic hydrolysate obtained according to the method of any one of claims 5 to 7 or a bird's nest enzymatic hydrolysate comprising the polypeptide of any one of claims 1 to 4.
9. Use of the polypeptide according to any one of claims 1 to 4 or the enzymatic hydrolysate of the bird's nest according to claim 8 in the preparation of a product, wherein the product has at least one of the following uses: Maintain or increase the moisture content of the skin; Prevent and / or slow down skin aging; Prevent and / or slow down skin UVB damage; Promote the healing of skin wounds or wounds; Optionally, the product includes but is not limited to: at least one of medicines, foods, health products, and cosmetics; Optionally, the drug is used for the prevention and / or healing of skin UVB damage or skin wounds or wound surfaces; Optionally, the health product helps improve skin moisture status, helps improve melasma, or helps improve acne.
10. A medicine, food, health product or cosmetic, It is characterized in that include: The polypeptide according to any one of claims 1 to 4 or the bird's nest enzymatic hydrolysate according to claim 8.
Citation Information
Cited By
Antioxidant peptide as well as preparation method and application thereof
CN119874809A
Antioxidant peptides, methods of making and using the same
CN119874809B
Bird's nest peptide for inhibiting xanthine oxidase and application of bird's nest peptide
CN121021622A
Alcohol dehydrogenase activating cubilose peptide and application thereof
CN121021623A
Preparation method and application of cubilose peptide
CN121248719A
